Lane BR - Search Results

1

Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A.

Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Hayes MM, et al. Among authors: lane br. Cell Immunol. 2002 Jan;215(1):61-71. doi: 10.1016/s0008-8749(02)00017-5. Cell Immunol. 2002. PMID: 12142037

2

Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects.

Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Hayes MM, et al. Among authors: lane br. J Biol Chem. 2002 May 10;277(19):16913-9. doi: 10.1074/jbc.M200875200. Epub 2002 Feb 14. J Biol Chem. 2002. PMID: 11847231 Free article.

3

The C-X-C chemokine IP-10 stimulates HIV-1 replication.

Lane BR, King SR, Bock PJ, Strieter RM, Coffey MJ, Markovitz DM. Lane BR, et al. Virology. 2003 Mar 1;307(1):122-34. doi: 10.1016/s0042-6822(02)00045-4. Virology. 2003. PMID: 12667820 Free article.

4

TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.

Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ. Lane BR, et al. J Immunol. 1999 Oct 1;163(7):3653-61. J Immunol. 1999. PMID: 10490959

5

Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes.

Lane BR, Strieter RM, Coffey MJ, Markovitz DM. Lane BR, et al. J Virol. 2001 Jul;75(13):5812-22. doi: 10.1128/JVI.75.13.5812-5822.2001. J Virol. 2001. PMID: 11390582 Free PMC article.

6

Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Lane BR, Liu J, Bock PJ, Schols D, Coffey MJ, Strieter RM, Polverini PJ, Markovitz DM. Lane BR, et al. J Virol. 2002 Nov;76(22):11570-83. doi: 10.1128/jvi.76.22.11570-11583.2002. J Virol. 2002. PMID: 12388718 Free PMC article.

7

Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate.

Faulkner NE, Lane BR, Bock PJ, Markovitz DM. Faulkner NE, et al. Among authors: lane br. J Virol. 2003 Feb;77(3):2276-81. doi: 10.1128/jvi.77.3.2276-2281.2003. J Virol. 2003. PMID: 12525665 Free PMC article.

8

Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy.

Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM, Markovitz DM. Lane BR, et al. J Virol. 2001 Sep;75(17):8195-202. doi: 10.1128/jvi.75.17.8195-8202.2001. J Virol. 2001. PMID: 11483765 Free PMC article.

9

GLI-2 modulates retroviral gene expression.

Smith MJ, Gitlin SD, Browning CM, Lane BR, Clark NM, Shah N, Rainier S, Markovitz DM. Smith MJ, et al. Among authors: lane br. J Virol. 2001 Mar;75(5):2301-13. doi: 10.1128/JVI.75.5.2301-2313.2001. J Virol. 2001. PMID: 11160733 Free PMC article.

10

Human GLI-2 is a tat activation response element-independent Tat cofactor.

Browning CM, Smith MJ, Clark NM, Lane BR, Parada C, Montano M, KewalRamani VN, Littman DR, Essex M, Roeder RG, Markovitz DM. Browning CM, et al. Among authors: lane br. J Virol. 2001 Mar;75(5):2314-23. doi: 10.1128/JVI.75.5.2314-2323.2001. J Virol. 2001. PMID: 11160734 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page